脂肪因子与妊娠期糖尿病及糖脂代谢

doi:10.12280/gjszjk.20200617

摘要/Abstract

摘要：

妊娠期糖尿病（gestational diabetes mellitus,GDM）是妊娠期的主要并发症之一,随着我国二孩政策的实施、生活水平的提高、婚姻观念的转变,在肥胖、高龄和遗传易感性等高危因素的影响下,GDM的发病率呈逐年上升趋势。目前GDM的具体发病机制尚不明确,可能与胰岛素抵抗及胰岛β细胞功能缺陷有关。GDM孕妇体内糖代谢的紊乱会进一步导致脂质代谢的异常,从而引发不良妊娠结局。其中脂肪因子,如促代谢因子（betatrophin）、趋化素（chemerin）、C1q/肿瘤坏死因子相关蛋白（CTRP9）和瘦素（leptin）等在GDM的相关发病机制中可能起到一定作用。综述脂肪因子在调节糖脂代谢中的作用,及其在GDM病理发生中的作用。

关键词: 糖尿病,妊娠, 胰岛素抗药性, 脂肪因子类, 葡萄糖代谢障碍, 瘦素, 脂质代谢

Abstract:

Gestational diabetes mellitus (GDM) is one of the major complications during pregnancy. With the implementation of the two-child policy, the improvement of living standard and the change of marriage concept, the incidence of GDM has been increasing year by year under the influence of high risk factors such as obesity, age and genetic susceptibility. At present, the specific pathogenesis of GDM is not clear, which may be related to insulin resistance and dysfunction of insulin β cell. The disorder of glucose metabolism in pregnant women with GDM will further lead to the disorder of lipid metabolism, leading to adverse pregnant outcomes. Adipokines, such as betatrophin, chemerin, C1q/tumor necrosis factor related protein (CTRP9) and leptin, may play a role in the pathogenesis of GDM. This article reviews the roles of adipokines in the regulation of glucose and lipid metabolism, and the pathogenesis of GDM.

Key words: Diabetes, gestational, Insulin resistance, Adipokines, Glucose metabolism disorders, Leptin, Lipid metabolism

郑凯, 袁晶. 脂肪因子与妊娠期糖尿病及糖脂代谢[J]. 国际生殖健康/计划生育, 2021, 40(5): 431-435.

ZHENG Kai, YUAN Jing. Adipokines and Gestational Diabetes Mellitus and Glucose Lipid Metabolism[J]. Journal of International Reproductive Health/Family Planning, 2021, 40(5): 431-435.

参考文献 35

[1]	谢幸, 孔北华, 段涛. 妇产科学[M]. 9版. 北京: 人民卫生出版社, 2018:105-109.
[2]	Huang L, Yue P, Wu X, et al. Combined intervention of swimming plus metformin ameliorates the insulin resistance and impaired lipid metabolism in murine gestational diabetes mellitus[J]. PLoS One, 2018, 13(4):e0195609. doi: 10.1371/journal.pone.0195609. doi: 10.1371/journal.pone.0195609 URL
[3]	Skajaa GO, Fuglsang J, Knorr S, et al. Changes in insulin sensitivity and insulin secretion during pregnancy and post partum in women with gestational diabetes[J]. BMJ Open Diabetes Res Care, 2020, 8(2):e001728. doi: 10.1136/bmjdrc-2020-001728. doi: 10.1136/bmjdrc-2020-001728 URL
[4]	Samuel OO. Review on multifaceted involvement of perivascular adipose tissue in vascular pathology[J]. Cardiovasc Pathol, 2020, 49:107259. doi: 10.1016/j.carpath.2020.107259. doi: 10.1016/j.carpath.2020.107259 URL
[5]	Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic β cell proliferation[J]. Cell, 2013, 153(4):747-758. doi: 10.1016/j.cell.2013.04.008. doi: 10.1016/j.cell.2013.04.008 URL
[6]	陈香娟. 妊娠期糖尿病孕妇血清中的Betatrophin表达及糖脂代谢分析[J]. 中国现代药物应用, 2020, 14(16):31-32. doi: 10.14164/j.cnki.cn11-5581/r.2020.16.012. doi: 10.14164/j.cnki.cn11-5581/r.2020.16.012
[7]	Kong FJ, Ma LL, Li G, et al. Circulating Betatrophin Levels and Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis[J]. PLoS One, 2017, 12(1):e0169941. doi: 10.1371/journal.pone.0169941. doi: 10.1371/journal.pone.0169941 URL
[8]	陈龙, 王曼, 刘利平. 妊娠期糖尿病患者血清Betatrophin含量检测及其与机体糖脂代谢紊乱的相关关系[J]. 海南医学院学报, 2018, 24(22):1959-1962. doi: 10.13210/j.cnki.jhmu.20181106.001. doi: 10.13210/j.cnki.jhmu.20181106.001
[9]	Gusarova V, Alexa CA, Na E, et al. ANGPTL8/betatrophin does not control pancreatic beta cell expansion[J]. Cell, 2014, 159(3):691-696. doi: 10.1016/j.cell.2014.09.027. doi: 10.1016/j.cell.2014.09.027 URL
[10]	Ministrini S, Ricci MA, Nulli Migliola E, et al. Chemerin predicts carotid intima-media thickening in severe obesity[J]. Eur J Clin Invest, 2020 Apr 29:e13256. doi: 10.1111/eci.13256.Epub ahead of print. doi: 10.1111/eci.13256.Epub ahead of print
[11]	Goralski KB, Jackson AE, McKeown BT, et al. More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer[J]. Int J Mol Sci, 2019, 20(19):4778. doi: 10.3390/ijms20194778. doi: 10.3390/ijms20194778 URL
[12]	Yang X, Quan X, Lan Y, et al. Serum chemerin level during the first trimester of pregnancy and the risk of gestational diabetes mellitus[J]. Gynecol Endocrinol, 2017, 33(10):770-773. doi: 10.1080/09513590.2017.1320382. doi: 10.1080/09513590.2017.1320382 URL
[13]	赵欣媛, 郑雪绒, 张建华. 妊娠期糖尿病患者血清Vaspin、Chemerin及CRP水平表达及临床意义[J]. 中国妇幼保健, 2018, 33(15):3375-3378. doi: 10.7620/zgfybj.j.issn.1001-4411.2018.15.04. doi: 10.7620/zgfybj.j.issn.1001-4411.2018.15.04
[14]	王晓烔, 张晓柯, 胡廉. 脂肪因子对睾丸雄激素生成的调节作用[J]. 国际生殖健康/计划生育杂志, 2016, 35(5):395-399.doi: 10.3969/j.issn.1674-1889.2016.05.010. doi: 10.3969/j.issn.1674-1889.2016.05.010
[15]	Qiu H, Liu X, Yao S, et al. Regulation and Mechanism of miR-518d through the PPARα-Mediated NF-κB Pathway in the Development of Gestational Diabetes Mellitus[J]. J Diabetes Res, 2020, 2020:7019597. doi: 10.1155/2020/7019597. doi: 10.1155/2020/7019597
[16]	Zhang Z, Wang J, Wang H. Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus[J]. Exp Ther Med, 2018, 15(3):2936-2940. doi: 10.3892/etm.2018.5753. doi: 10.3892/etm.2018.5753
[17]	付竹梅, 王培英, 郭永. 妊娠期糖尿病患者血清脂肪因子chemerin的表达与糖脂代谢的关系[J]. 中国民康医学, 2020, 32(1):23-25. doi: 10.3969/j.issn.1672-0369.2020.01.010. doi: 10.3969/j.issn.1672-0369.2020.01.010
[18]	Zuo A, Zhao X, Li T, et al. CTRP9 knockout exaggerates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy through inhibiting the LKB1/AMPK pathway[J]. J Cell Mol Med, 2020, 24(4):2635-2647. doi: 10.1111/jcmm.14982. doi: 10.1111/jcmm.14982 URL
[19]	Yang G, Song Q, Sun C, et al. Ctrp9 and adiponectin receptors in Nile tilapia (Oreochromis niloticus): Molecular cloning, tissue distribution and effects on reproductive genes[J]. Gen Comp Endocrinol, 2018, 265:160-173. doi: 10.1016/j.ygcen.2018.05.033. doi: 10.1016/j.ygcen.2018.05.033 URL
[20]	Li W, Ma N, Liu MX, et al. C1q/TNF-related protein-9 attenuates retinal inflammation and protects blood-retinal barrier in db/db mice[J]. Eur J Pharmacol, 2019, 853:289-298. doi: 10.1016/j.ejphar.2019.04.012. doi: 10.1016/j.ejphar.2019.04.012 URL
[21]	蒋慰, 鲁燕. C1q/肿瘤坏死因子相关蛋白9与代谢相关疾病的基础研究进展[J]. 中国糖尿病杂志, 2018, 26(5):427-430. doi: 10.3969/j.issn.1006-6187.2018.05.016. doi: 10.3969/j.issn.1006-6187.2018.05.016
[22]	严苗, 杨金华, 潘治玉. 妊娠期糖尿病患者血清CTRP9、趋化素水平与糖脂代谢及胰岛功能的相关性分析[J]. 中国妇幼保健, 2020, 35(4):606-608. doi: 10.19829/j.zgfybj.issn.1001-4411.2020.04.007. doi: 10.19829/j.zgfybj.issn.1001-4411.2020.04.007
[23]	李秀娟, 郑雪绒, 张建华, 等. 妊娠期糖尿病患者血清CTRP9 TNF-α及脂联素水平与胰岛素抵抗的关系[J]. 河北医学, 2017, 23(11):1855-1857. doi: 10.3969/j.issn.1006-6233.2017.11.027. doi: 10.3969/j.issn.1006-6233.2017.11.027
[24]	杨瑞, 张存娟, 邢文娟, 等. 脂肪因子CTRP9对低氧性肺动脉高压大鼠肺血管的舒张作用及其机制[J]. 心脏杂志, 2016, 28(1):1-6. doi: 10.13191/j.chj.2016.0001. doi: 10.13191/j.chj.2016.0001
[25]	Sun H, Zhu X, Zhou Y, et al. C1q/TNF-Related Protein-9 Ameliorates Ox-LDL-Induced Endothelial Dysfunction via PGC-1α/AMPK-Mediated Antioxidant Enzyme Induction[J]. Int J Mol Sci, 2017, 18(6):1097. doi: 10.3390/ijms18061097. doi: 10.3390/ijms18061097 URL
[26]	谢奇君, 刘岚. MiRNAs与妊娠期糖尿病发病机制的研究进展[J]. 国际妇产科学杂志, 2019, 46(4):402-406. doi: 10.3969/j.issn.1674-1870.2019.04.010. doi: 10.3969/j.issn.1674-1870.2019.04.010
[27]	Bouafi H, Bencheikh S, Mehdi Krami AL, et al. Prediction and Structural Comparison of Deleterious Coding Nonsynonymous Single Nucleotide Polymorphisms (nsSNPs) in Human LEP Gene Associated with Obesity[J]. Biomed Res Int, 2019, 2019:1832084. doi: 10.1155/2019/1832084. doi: 10.1155/2019/1832084 pmid: 31871931
[28]	Katsiki N, Mikhailidis DP, Banach M. Leptin, cardiovascular diseases and type 2 diabetes mellitus[J]. Acta Pharmacol Sin, 2018, 39(7):1176-1188. doi: 10.1038/aps.2018.40. doi: 10.1038/aps.2018.40 pmid: 29877321
[29]	Pérez-Pérez A, Toro A, Vilariño-García T, et al. Leptin action in normal and pathological pregnancies[J]. J Cell Mol Med, 2018, 22(2):716-727. doi: 10.1111/jcmm.13369. doi: 10.1111/jcmm.13369 pmid: 29160594
[30]	Engin A. Diet-Induced Obesity and the Mechanism of Leptin Resistance[J]. Adv Exp Med Biol, 2017, 960:381-397. doi: 10.1007/978-3-319-48382-5_16. doi: 10.1007/978-3-319-48382-5_16
[31]	Sertie R, Kang M, Antipenko JP, et al. In utero nutritional stress as a cause of obesity: Altered relationship between body fat, leptin levels and caloric intake in offspring into adulthood[J]. Life Sci, 2020, 254:117764. doi: 10.1016/j.lfs.2020.117764. doi: 10.1016/j.lfs.2020.117764 URL
[32]	Cochrane VA, Wu Y, Yang Z, et al. Leptin modulates pancreatic β-cell membrane potential through Src kinase-mediated phosphorylation of NMDA receptors[J]. J Biol Chem, 2020, 295(50):17281-17297. doi: 10.1074/jbc.RA120.015489. doi: 10.1074/jbc.RA120.015489 URL
[33]	钱婷婷, 陈丹青. 妊娠期糖尿病高危因素的研究进展[J]. 国际妇产科学杂志, 2019, 46(5):494-498. doi: 10.3969/j.issn.1674-1870.2019.05.003. doi: 10.3969/j.issn.1674-1870.2019.05.003
[34]	李程, 夏纪毅, 万沁. Nrf2/ARE通路对2型糖尿病大鼠胰岛B细胞的保护作用[J]. 中华内分泌外科杂志, 2016, 10(3):201-205. doi: 10.3760/cma.j.issn.1674-6090.2016.03.007. doi: 10.3760/cma.j.issn.1674-6090.2016.03.007
[35]	吴燕华, 董琛琛, 廖奇峰. 脂联素、瘦素水平变化对妊娠糖尿病孕妇发病率的影响[J]. 实用糖尿病杂志, 2020, 16(5):107-108.